117 related articles for article (PubMed ID: 35189090)
1. Inhibition of abnormally activated HIF-1α-GLUT1/3-glycolysis pathway enhances the sensitivity of hepatocellular carcinoma to 5-caffeoylquinic acid and its derivatives.
Pang Y; Lin Y; Wang X; Wang J; Liu Q; Ding N; Huang L; Xiang Q; Fang J; Tan G; Lyu J; Wang Z
Eur J Pharmacol; 2022 Apr; 920():174844. PubMed ID: 35189090
[TBL] [Abstract][Full Text] [Related]
2. Dihydroartemisinin breaks the positive feedback loop of YAP1 and GLUT1-mediated aerobic glycolysis to boost the CD8
Gao Y; Gong Y; Lu J; Yang Y; Zhang Y; Xiong Y; Shi X
Biochem Pharmacol; 2024 Jul; 225():116294. PubMed ID: 38754557
[TBL] [Abstract][Full Text] [Related]
3. Genistein suppresses aerobic glycolysis and induces hepatocellular carcinoma cell death.
Li S; Li J; Dai W; Zhang Q; Feng J; Wu L; Liu T; Yu Q; Xu S; Wang W; Lu X; Chen K; Xia Y; Lu J; Zhou Y; Fan X; Mo W; Xu L; Guo C
Br J Cancer; 2017 Nov; 117(10):1518-1528. PubMed ID: 28926527
[TBL] [Abstract][Full Text] [Related]
4. FOXM1 regulates glycolysis in hepatocellular carcinoma by transactivating glucose transporter 1 expression.
Shang R; Pu M; Li Y; Wang D
Oncol Rep; 2017 Apr; 37(4):2261-2269. PubMed ID: 28260073
[TBL] [Abstract][Full Text] [Related]
5. BTF3 promotes proliferation and glycolysis in hepatocellular carcinoma by regulating GLUT1.
Wang P; Sun J; Sun C; Zhao H; Zhang Y; Chen J
Cancer Biol Ther; 2023 Dec; 24(1):2225884. PubMed ID: 37382415
[TBL] [Abstract][Full Text] [Related]
6. Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis.
Feng J; Dai W; Mao Y; Wu L; Li J; Chen K; Yu Q; Kong R; Li S; Zhang J; Ji J; Wu J; Mo W; Xu X; Guo C
J Exp Clin Cancer Res; 2020 Jan; 39(1):24. PubMed ID: 32000827
[TBL] [Abstract][Full Text] [Related]
7. Yes-associated protein (YAP) binds to HIF-1α and sustains HIF-1α protein stability to promote hepatocellular carcinoma cell glycolysis under hypoxic stress.
Zhang X; Li Y; Ma Y; Yang L; Wang T; Meng X; Zong Z; Sun X; Hua X; Li H
J Exp Clin Cancer Res; 2018 Sep; 37(1):216. PubMed ID: 30180863
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA SLC2A1-AS1 regulates aerobic glycolysis and progression in hepatocellular carcinoma via inhibiting the STAT3/FOXM1/GLUT1 pathway.
Shang R; Wang M; Dai B; Du J; Wang J; Liu Z; Qu S; Yang X; Liu J; Xia C; Wang L; Wang D; Li Y
Mol Oncol; 2020 Jun; 14(6):1381-1396. PubMed ID: 32174012
[TBL] [Abstract][Full Text] [Related]
9. PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma.
Feng J; Wu L; Ji J; Chen K; Yu Q; Zhang J; Chen J; Mao Y; Wang F; Dai W; Xu L; Wu J; Guo C
J Exp Clin Cancer Res; 2019 May; 38(1):204. PubMed ID: 31101057
[TBL] [Abstract][Full Text] [Related]
10. Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma.
Feng J; Li J; Wu L; Yu Q; Ji J; Wu J; Dai W; Guo C
J Exp Clin Cancer Res; 2020 Jul; 39(1):126. PubMed ID: 32631382
[TBL] [Abstract][Full Text] [Related]
11. GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis.
Amann T; Maegdefrau U; Hartmann A; Agaimy A; Marienhagen J; Weiss TS; Stoeltzing O; Warnecke C; Schölmerich J; Oefner PJ; Kreutz M; Bosserhoff AK; Hellerbrand C
Am J Pathol; 2009 Apr; 174(4):1544-52. PubMed ID: 19286567
[TBL] [Abstract][Full Text] [Related]
12. circ-PRKCI targets miR-1294 and miR-186-5p by downregulating FOXK1 expression to suppress glycolysis in hepatocellular carcinoma.
Chen W; Li Y; Zhong J; Wen G
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880589
[TBL] [Abstract][Full Text] [Related]
13. Caffeoylquinic Acid Derivatives of Purple Sweet Potato as Modulators of Mitochondrial Function in Mouse Primary Hepatocytes.
Torres A; Noriega LG; Delgadillo-Puga C; Tovar AR; Navarro-Ocaña A
Molecules; 2021 Jan; 26(2):. PubMed ID: 33435516
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-inducible transcription factor-1alpha promotes hypoxia-induced A549 apoptosis via a mechanism that involves the glycolysis pathway.
Luo F; Liu X; Yan N; Li S; Cao G; Cheng Q; Xia Q; Wang H
BMC Cancer; 2006 Jan; 6():26. PubMed ID: 16438736
[TBL] [Abstract][Full Text] [Related]
15. Autophagy promotes metastasis and glycolysis by upregulating MCT1 expression and Wnt/β-catenin signaling pathway activation in hepatocellular carcinoma cells.
Fan Q; Yang L; Zhang X; Ma Y; Li Y; Dong L; Zong Z; Hua X; Su D; Li H; Liu J
J Exp Clin Cancer Res; 2018 Jan; 37(1):9. PubMed ID: 29351758
[TBL] [Abstract][Full Text] [Related]
16. TFB2M activates aerobic glycolysis in hepatocellular carcinoma cells through the NAD
Chang H; Li J; Luo Y; Wu B; Yuan C; Geng X
J Gastroenterol Hepatol; 2021 Oct; 36(10):2978-2988. PubMed ID: 33982328
[TBL] [Abstract][Full Text] [Related]
17. Glycolysis module activated by hypoxia-inducible factor 1alpha is related to the aggressive phenotype of hepatocellular carcinoma.
Hamaguchi T; Iizuka N; Tsunedomi R; Hamamoto Y; Miyamoto T; Iida M; Tokuhisa Y; Sakamoto K; Takashima M; Tamesa T; Oka M
Int J Oncol; 2008 Oct; 33(4):725-31. PubMed ID: 18813785
[TBL] [Abstract][Full Text] [Related]
18. RRAD inhibits aerobic glycolysis, invasion, and migration and is associated with poor prognosis in hepatocellular carcinoma.
Shang R; Wang J; Sun W; Dai B; Ruan B; Zhang Z; Yang X; Gao Y; Qu S; Lv X; Tao K; Wang L; Dou K; Wang D
Tumour Biol; 2016 Apr; 37(4):5097-105. PubMed ID: 26546438
[TBL] [Abstract][Full Text] [Related]
19. CD147 promotes reprogramming of glucose metabolism and cell proliferation in HCC cells by inhibiting the p53-dependent signaling pathway.
Huang Q; Li J; Xing J; Li W; Li H; Ke X; Zhang J; Ren T; Shang Y; Yang H; Jiang J; Chen Z
J Hepatol; 2014 Oct; 61(4):859-66. PubMed ID: 24801417
[TBL] [Abstract][Full Text] [Related]
20. [Pandanus tectorius derived caffeoylquinic acids inhibit lipid accumulation in HepG2 hepatoma cells through regulation of gene expression involved in lipid metabolism].
Wu CM; Luan H; Wang S; Zhang XP; Liu HT; Guo P
Yao Xue Xue Bao; 2015 Mar; 50(3):278-83. PubMed ID: 26118105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]